NasdaqGS:OPKHealthcare
Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook?
Phillip Frost, CEO and Chairman of OPKO Health, and Frost Gamma Investments Trust recently acquired US$737,747 worth of OPKO Health shares, significantly increasing Frost's ownership both directly and indirectly.
This activity coincided with a downgrade from Jefferies, who shifted their rating from Buy to Hold due to concerns over flat sales guidance for Ngenla, a growth hormone product developed with Pfizer.
To assess how insider buying by the CEO could influence OPKO Health’s outlook,...